| Literature DB >> 27706109 |
Hang Shao1,2, Wen-Li Mei3, Wen-Hua Dong4, Cui-Juan Gai5, Wei Li6, Guo-Peng Zhu7, Hao-Fu Dai8.
Abstract
Three new2-(2-phenylethyl)chromone derivatives (1-3) and a new2-(2-phenylethenyl)chromone derivative (4), together with two known 2-(2-phenylethyl)chromone derivatives (5-6), were isolated from agarwood originating from Gyrinops salicifolia Ridl. The structures of compounds 1-4 were elucidated by comprehensive spectroscopic techniques (UV, IR, 1D and 2D-NMR) and MS analysis, as well as by comparison with the literature. Compounds 1, 2, and 5 showed moderate cytotoxicity against human tumor K562, BEL-7402, and SGC-7901 cell lines with IC50 values of 5.76 to 20.1 µM.Entities:
Keywords: 2-(2-phenylethenyl)chromone derivative; 2-(2-phenylethyl)chromone derivative; Gyrinops salicifolia; agarwood; cytotoxicity
Mesh:
Substances:
Year: 2016 PMID: 27706109 PMCID: PMC6273548 DOI: 10.3390/molecules21101313
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structure of compounds 1–6.
1H- (500 MHz) and 13C- (125 MHz) NMR spectral data of compounds 1–4 (δ in ppm, J in Hz).
| No. | 1 a | 2 a | 3 a | 4 b | ||||
|---|---|---|---|---|---|---|---|---|
| δC | δH | δC | δH | δC | δH | δC | δH | |
| 2 | 167.2 | 167.8 | 170.8 | 163.6 | ||||
| 3 | 108.6 | 5.99 s | 108.9 | 6.03 s | 108.4 | 6.22 s | 108.4 | 6.22 s |
| 4 | 176.0 | 176.3 | 183.1 | 183.7 | ||||
| 5 | 107.6 | 7.22 s | 107.3 | 7.23 s | 151.2 | 161.5 | ||
| 6 | 144.3 | 145.1 | 109.8 | 6.61 d (8.2), overlap | 111.4 | 6.79 d (8.3) | ||
| 7 | 152.0 | 153.6 | 121.8 | 7.17 d (8.2) | 135.4 | 7.51 t (8.3) | ||
| 8 | 102.8 | 6.84 s | 100.4 | 7.12 s | 137.6 | 106.9 | 6.96 d (8.3) | |
| 9 | 151.0 | 151.1 | 144.5 | 156.4 | ||||
| 10 | 115.8 | 116.6 | 110.4 | 111.1 | ||||
| 1′ | 140.2 | 132.1 | 132.5 | 127.7 | ||||
| 2′ | 128.4 | 7.26 m | 129.4 | 7.15 d (8.5) | 115.7 | 6.67 d (2.2) | 129.6 | 7.54 d (8.1) |
| 3′ | 128.3 | 7.26 m | 113.9 | 6.83 d (8.5) | 146.2 | 114.7 | 6.95 d (8.1) | |
| 4′ | 126.2 | 7.19 m | 157.8 | 146.4 | 161.0 | |||
| 5′ | 128.3 | 7.26 m | 113.9 | 6.83 d (8.5) | 112.3 | 6.80 d (8.2) | 114.7 | 6.95 d (8.1) |
| 6′ | 128.4 | 7.26 m | 129.4 | 7.15 d (8.5) | 118.8 | 6.61 d (2.2, 8.2), overlap | 129.6 | 7.54 d (8.1) |
| 7′ | 32.1 | 2.97 m | 31.4 | 2.90 m | 31.2 | 2.92 m | 137.9 | 7.59 d (16.0) |
| 8′ | 34.7 | 2.90 m | 35.2 | 2.90 m | 35.2 | 2.92 m | 117.3 | 6.63 d (16.0) |
| 5-OH | 11.85 s | |||||||
| 6-OH | 9.70 s | 9.72 s | ||||||
| 7-OH | 10.35 s | |||||||
| 8-OH | 9.67 s | |||||||
| 3′-OH | 8.85 s | |||||||
| 7-OCH3 | 56.3 | 3.89 s | ||||||
| 4′-OCH3 | 55.0 | 3.70 s | 55.6 | 3.71 s | 55.6 | 3.86 s | ||
Measured in DMSO-d6, Measured in CDCl3.
Figure 2Key HMBC, ROESY, and 1H-1H COSY correlations of compounds 1–4.
Cytotoxic activity of 1–6 against human tumor cell lines.
| Compound | IC50 (μM) | ||
|---|---|---|---|
| SGC-7901 | K-562 | BEL-7402 | |
| >50 | 18.1 | 20.1 | |
| 17.8 | 13.9 | 31.9 | |
| >50 | >50 | >50 | |
| >50 | >50 | >50 | |
| >50 | 8.36 | 5.76 | |
| >50 | 47.0 | >50 | |
| Paclitaxel b | 1.80 | 7.20 | 2.40 |
b positive control.